■关节镜上囊重建(ASCR)和反向肩关节置换术(RSA)在不可修复的肩袖撕裂(IRCT)患者中均显示出良好的预后。
■目的:(1)比较65岁以上合并IRCT的患者ASCR与RSA的临床结局;(2)比较治疗组之间临床结局的系列变化。
■队列研究;证据水平,3.
这项研究纳入了在2013年3月至2020年12月期间接受了ASCR或RSA治疗且至少有2年随访数据的无肱骨关节炎患者。我们评估了活动范围,视觉模拟量表(VAS)疼痛评分,美国肩肘外科医师(ASES)评分,和术前单一评估数字评估(SANE)评分,短期(术后6-12个月),和最后的随访时间。
■总共,64名患者(ASCR,31例患者;RSA,包括33名患者)。患者的平均年龄为71.3±4.4和72.9±4.1岁,ASCR组和RSA组的平均最终随访时间为42±21.8和37.7±21.7个月,分别。在短期随访中,RSA在所有临床结果中都取得了显着改善,除了内部旋转(IR),虽然ASCR仅显示VAS疼痛的显着改善,ASES,和SANE得分。与术前相比,ASCR和RSA在所有临床结果中均取得了显着改善,最终随访时RSA组的IR除外。ASCR组在最后的随访中取得了较好的IR和ASES评分,而RSA后假性麻痹恢复所需的时间更短。ASCR组在1年随访时移植物愈合率为67.8%,而RSA组在最后一次随访时显示12.1%的肩胛骨缺口。两组均未出现其他术后并发症。
■ASCR和RSA在研究队列中取得了良好的临床结果。在短期随访中,RSA在所有临床结果中均显示出显着改善,除了IR,虽然ASCR仅显示VAS疼痛的显着改善,ASES,和SANE得分。在最后的后续行动中,然而,与RSA相比,ASCR具有更好的IR和ASES评分。
UNASSIGNED: Arthroscopic superior capsular reconstruction (ASCR) and reverse shoulder arthroplasty (RSA) have both shown favorable outcomes in patients with irreparable rotator cuff tears (IRCTs).
UNASSIGNED: To (1) compare the clinical outcomes of ASCR versus RSA in patients aged ≥65 years with IRCTs and (2) compare serial changes in clinical outcomes between treatment groups.
UNASSIGNED: Cohort study; Level of evidence, 3.
UNASSIGNED: This study included patients with IRCTs without glenohumeral osteoarthritis who underwent either ASCR or RSA between March 2013 and December 2020 and had at least 2 years of follow-up data. We assessed active range of motion, a visual analog scale (VAS) pain score, the American Shoulder and Elbow Surgeons (ASES) score, and the Single Assessment Numeric Evaluation (SANE) score at the preoperative, short-term (postoperative 6-12 months), and final follow-up times.
UNASSIGNED: In total, 64 patients (ASCR, 31 patients; RSA, 33 patients) were included. The mean age of patients was 71.3 ± 4.4 and 72.9 ± 4.1 years, and the mean final follow-up duration was 42 ± 21.8 and 37.7 ± 21.7 months in the ASCR and RSA groups, respectively. At the short-term follow-up, RSA achieved significant improvements in all clinical outcomes, except for internal rotation (IR), while ASCR only showed significant improvements in VAS pain, ASES, and SANE scores. Compared with the preoperative period, both ASCR and RSA achieved significant improvements in all clinical outcomes, except for IR in the RSA group at the final follow-up. The ASCR group achieved better IR and ASES scores at the final follow-up, while the time taken to recover from pseudoparalysis was shorter after RSA. The ASCR group showed a 67.8% graft healing rate at the 1-year follow-up, while the RSA group showed 12.1% of scapular notching at the final follow-up. No other postoperative complications were observed in either group.
UNASSIGNED: ASCR and RSA achieved favorable clinical outcomes in the study cohort. At the short-term follow-up, RSA showed significant improvements in all clinical outcomes, except for IR, while ASCR only showed significant improvements in VAS pain, ASES, and SANE scores. At the final follow-up, however, ASCR had better IR and ASES scores compared with RSA.